Blockade of antimicrobial proteins S100A8 and S100A9 inhibits phagocyte migration to the alveoli in streptococcal pneumonia

Journal of Immunology

Volumn 180, Issue 5, 2008, Pages 3366-3374

  Raquil, Marie Astrid ^a   Anceriz, Nadia ^a   Rouleau, Pascal ^a   Tessier, Philippe A ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN A; CALGRANULIN B; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN ANTIBODY; ANTIMICROBIAL CATIONIC PEPTIDE; BLOCKING ANTIBODY;

ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; FEMALE; INNATE IMMUNITY; LEUKOCYTE COUNT; LEUKOCYTE MIGRATION; LUNG ALVEOLUS; LUNG ALVEOLUS CELL; LUNG BLOOD VESSEL; LUNG LAVAGE; LUNG PARENCHYMA; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; STREPTOCOCCUS PNEUMONIA; SURVIVAL; ANIMAL; BACTERIAL PNEUMONIA; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; IMMUNOLOGY; LEUKOCYTE MIGRATION INHIBITION TEST; LUNG; METABOLISM; MICROBIOLOGY; MONOCYTE; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHYSIOLOGY; RESPIRATORY TRACT MUCOSA; SECRETION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TIME; ULTRASTRUCTURE;

ANIMALS; ANTIBODIES, BLOCKING; ANTIMICROBIAL CATIONIC PEPTIDES; CALGRANULIN A; CALGRANULIN B; CELL MIGRATION INHIBITION; DISEASE MODELS, ANIMAL; LUNG; MICE; MONOCYTES; NEUTROPHIL INFILTRATION; NEUTROPHILS; PHAGOCYTES; PNEUMONIA, BACTERIAL; PULMONARY ALVEOLI; RESPIRATORY MUCOSA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS;

EID: 49149106181     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.5.3366     Document Type: Article

References (48)

1. Yang, D., Q. Chen, D. M. Hoover, P. Staley, K. D. Tucker, J. Lubkowski, and J. J. Oppenheim. 2003. Many chemokines including CCL20/MIP-3α display antimicrobial activity. J. Leukocyte Biol. 74: 448-455.
2. Cole, A. M., T. Ganz, A. M. Liese, M. D. Burdick, L. Liu, and R. M. Strieter. 2001. Cutting edge: IFN-inducible ELR-CXC chemokines display defensin-like antimicrobial activity. J. Immunol. 167: 623-627.
3. Chertov, O., D. F. Michiel, L. Xu, J. M. Wang, K. Tani, W. J. Murphy, D. L. Longo, D. D. Taub, and J. J. Oppenheim. 1996. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J. Biol. Chem. 271: 2935-2940.
4. Chertov, O., H. Ueda, L. L. Xu, K. Tani, W. J. Murphy, J. M. Wang, O. M. Howard, T. J. Sayers, and J. J. Oppenheim. 1997. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J. Exp. Med. 186: 739-747.
5. Territo, M. C., T. Ganz, M. E. Selsted, and R. Lehrer. 1989. Monocyte-chemotactic activity of defensins from human neutrophils. J. Clin. Invest. 84: 2017-2020.
6. Striz, I., and I. Trebichavsky. 2004. Calprotectin: a pleiotropic molecule in acute and chronic inflammation. Physiol. Res. 53: 245-253.
7. Barthe, C., C. Figarella, J. Carrere, and O. Guy-Crotte. 1991. Identification of "cystic fibrosis protein" as a complex of two calcium-binding proteins present in human cells of myeloid origin. Biochim. Biophys. Acta 1096: 175-177.
8. Berntzen, H. B., U. Olmez, M. K. Fagerhol, and E. Munthe. 1991. The leukocyte protein L1 in plasma and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Scand. J. Rheumatol. 20: 74-82.
9. Hu, S. P., C. Harrison, K. Xu, C. J. Cornish, and C. L. Geczy. 1996. Induction of the chemotactic S100 protein, CP-10, in monocyte/macrophages by lipopolysaccharide. Blood 87: 3919-3928.
10. Lusitani, D., S. E. Malawista, and R. R. Montgomery. 2003. Calprotectin, an abundant cytosolic protein from human polymorphonuclear leukocytes, inhibits the growth of Borrelia burgdorferi. Infect. Immun. 71: 4711-4716.
11. Nisapakultorn, K., K. F. Ross, and M. C. Herzberg. 2001. Calprotectin expression inhibits bacterial binding to mucosal epithelial cells. Infect. Immun. 69: 3692-3696.
12. Santhanagopalan, V., B. L. Hahn, B. E. Dunn, J. H. Weissner, and P. G. Sohnle. 1995. Antimicrobial activity of calprotectin isolated from human empyema fluid supernatants. Clin. Immunol. Immunopathol. 76: 285-290.
13. Brandtzaeg, P., T. O. Gabrielsen, I. Dale, F. Muller, M. Steinbakk, and M. K. Fagerhol. 1995. The leucocyte protein L1 (calprotectin): a putative non-specific defence factor at epithelial surfaces. Adv. Exp. Med. Biol. 371A: 201-206.
14. Clohessy, P. A., and B. E. Golden. 1995. Calprotectin-mediated zinc chelation as a biostatic mechanism in host defence. Scand. J. Immunol. 42: 551-556.
15. Clohessy, P. A., and B. E. Golden. 1996. The mechanism of calprotectin's candidastatic activity appears to involve zinc chelation. Biochem. Soc. Trans. 24: 309S.
16. Miyasaki, K. T., A. L. Bodeau, A. R. Murthy, and R. I. Lehrer. 1993. In vitro antimicrobial activity of the human neutrophil cytosolic S-100 protein complex, calprotectin, against Capnocytophaga sputigena. J. Dent. Res. 72: 517-523.
17. Murthy, A. R., R. I. Lehrer, S. S. Harwig, and K. T. Miyasaki. 1993. In vitro candidastatic properties of the human neutrophil calprotectin complex. J. Immunol. 151: 6291-6301.
18. Nisapakultorn, K., K. F. Ross, and M. C. Herzberg. 2001. Calprotectin expression in vitro by oral epithelial cells confers resistance to infection by Porphyromonas gingivalis. Infect. Immun. 69: 4242-4247.
19. Sohnle, P. G., C. Collins-Lech, and J. H. Wiessner. 1991. The zinc-reversible antimicrobial activity of neutrophil lysates and abscess fluid supernatants. J. Infect. Dis. 164: 137-142.
20. Sohnle, P. G., M. J. Hunter, B. Hahn, and W. J. Chazin. 2000. Zinc-reversible antimicrobial activity of recombinant calprotectin (migration inhibitory factor-related proteins 8 and 14). J. Infect. Dis. 182: 1272-1275.
21. Berntzen, H. B., E. Munthe, and M. K. Fagerhol. 1989. A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis. J. Rheumatol. 16: 1416-1420.
22. Frosch, M., A. Strey, T. Vogl, N. M. Wulffraat, W. Kuis, C. Sunderkotter, E. Harms, C. Sorg, and J. Roth. 2000. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 43: 628-637.
23. Ryckman, C., C. Gilbert, R. de Medicis, A. Lussier, K. Vandal, and P. A. Tessier. 2004. Monosodium urate monohydrate crystals induce the release of the proinflammatory protein S100A8/A9 from neutrophils. J. Leukocyte Biol. 76: 433-440.
24. Odink, K., N. Cerletti, J. Bruggen, R. G. Clerc, L. Tarcsay, G. Zwadlo, G. Gerhards, R. Schlegel, and C. Sorg. 1987. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 330: 80-82.
25. Youssef, P., J. Roth, M. Frosch, P. Costello, O. Fitzgerald, C. Sorg, and B. Bresnihan. 1999. Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane. J. Rheumatol. 26: 2523-2528.
26. Ryckman, C., K. Vandal, P. Rouleau, M. Talbot, and P. A. Tessier. 2003. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J. Immunol. 170: 3233-3242.
27. Vandal, K., P. Rouleau, A. Boivin, C. Ryckman, M. Talbot, and P. A. Tessier. 2003. Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J. Immunol. 171: 2602-2609.
28. Cornish, C. J., J. M. Devery, P. Poronnik, M. Lackmann, D. I. Cook, and C. L. Geczy. 1996. S100 protein CP-10 stimulates myeloid cell chemotaxis without activation. J. Cell. Physiol. 166: 427-437.
29. Ryckman, C., S. R. McColl, K. Vandal, R. de Medicis, A. Lussier, P. E. Poubelle, and P. A. Tessier. 2003. Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis. Arthritis Rheum. 48: 2310-2320.
30. Kadioglu, A., and P. W. Andrew. 2004. The innate immune response to pneumococcal lung infection: the untold story. Trends Immunol. 25: 143-149.
31. Bergeron, Y., N. Ouellet, A. M. Deslauriers, M. Simard, M. Olivier, and M. G. Bergeron. 1998. Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice. Infect. Immun. 66: 912-922.
32. Reutershan, J., A. Basit, E. V. Galkina, and K. Ley. 2005. Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced acute lung injury. Am. J. Physiol. 289: L807-L815.
33. Passey, R. J., E. Williams, A. M. Lichanska, C. Wells, S. Hu, C. L. Geczy, M. H. Little, and D. A. Hume. 1999. A null mutation in the inflammation-associated S100 protein S100A8 causes early resorption of the mouse embryo. J. Immunol. 163: 2209-2216.
34. Ramisse, F., P. Binder, M. Szatanik, and J. M. Alonso. 1996. Passive and active immunotherapy for experimental pneumococcal pneumonia by polyvalent human immunoglobulin or F(ab′)2 fragments administered intranasally. J. Infect. Dis. 173: 1123-1128.
35. Ahmad, A., D. L. Bayley, S. He, and R. A. Stockley. 2003. Myeloid related protein-8/14 stimulates interleukin-8 production in airway epithelial cells. Am J. Respir. Cell Mol. Biol. 29: 523-530.
36. Sunahori, K., M. Yamamura, J. Yamana, K. Takasugi, M. Kawashima, H. Yamamoto, W. J. Chazin, Y. Nakatani, S. Yui, and H. Makino. 2006. The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor κB and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Res Ther. 8: R69.
37. Yang, D., O. Chertov, S. N. Bykovskaia, Q. Chen, M. J. Buffo, J. Shogan, M. Anderson, J. M. Schroder, J. M. Wang, O. M. Howard, and J. J. Oppenheim. 1999. β-Defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286: 525-528.
38. Fillion, I., N. Ouellet, M. Simard, Y. Bergeron, S. Sato, and M. G. Bergeron. 2001. Role of chemokines and formyl peptides in pneumococcal pneumonia-induced monocyte/macrophage recruitment. J. Immunol. 166: 7353-7361.
39. Rijneveld, A. W., G. P. van den Dobbelsteen, S. Florquin, T. J. Standiford, P. Speelman, L. van Alphen, and T. van der Poll. 2002. Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in mice. J. Infect. Dis. 185: 123-126.
40. Heit, B., S. Tavener, E. Raharjo, and P. Kubes. 2002. An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients. J. Cell Biol. 159: 91-102.
41. Coates, N. J., and S. R. McColl. 2001. Production of chemokines in vivo in response to microbial stimulation. J. Immunol. 166: 5176-5182.
42. + human monocytes. Int. Immunol. 12: 1593-1604.
43. Hurley, B. P., D. Siccardi, R. J. Mrsny, and B. A. McCormick. 2004. Polymorphonuclear cell transmigration induced by Pseudomonas aeruginosa requires the eicosanoid hepoxilin A3. J. Immunol. 173: 5712-5720.
44. Viemann, D., A. Strey, A. Janning, K. Jurk, K. Klimmek, T. Vogl, K. Hirono, F. Ichida, D. Foell, B. Kehrel, et al. 2005. Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood 105: 2955-2962.
45. 2 integrin Mac-1 on neutrophils. J. Immunol. 160: 1427-1435.
46. Edgeworth, J., M. Gorman, R. Bennett, P. Freemont, and N. Hogg. 1991. Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. J. Biol. Chem. 266: 7706-7713.
47. + T lymphocytes. J. Immunol. 169: 3307-3313.
48. Bozinovski, S., M. Cross, R. Vlahos, J. E. Jones, K. Hsuu, P. A. Tessier, E. C. Reynolds, D. A. Hume, J. A. Hamilton, C. L. Geczy, and G. P. Anderson. 2005. S100A8 chemotactic protein is abundantly increased, but only a minor contributor to LPS-induced, steroid resistant neutrophilic lung inflammation in vivo. J. Proteome Res. 4: 136-145.